News
Feed
Events
Feed
News
+ Events
Feed

Arix Bioscience PLC

  • ISIN GB00BD045071
  • Land Großbritannien

Aktuelle News

12 Februar 2024

13:00 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Scheme Effective

08:00 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Suspension of Trading in Shares

7 Februar 2024

12:30 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Transaction Update

29 Januar 2024

13:15 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Results of First General Meeting

24 Januar 2024

18:30 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Holding(s) in Company

18:30 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Holding(s) in Company

23 Januar 2024

08:00 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Update on the Scheme and Publication of Notice of Second General Meeting

22 Januar 2024

08:00 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Update on the Scheme and Resignation of Directors

19 Januar 2024

08:01 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Financial update on Harpoon Therapeutics acquisition by Merck (MSD)

08:00 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Unaudited NAV for December 2023

8 Januar 2024

18:15 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Portfolio company Harpoon Therapeutics to be acquired by Merck (MSD)

5 Januar 2024

08:00 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Publication of Circular and RTW Bio Prospectus

4 Januar 2024

18:30 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Holding(s) in Company

22 Dezember 2023

12:00 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Update regarding timing of Proposed Scheme of Reconstruction

13 Dezember 2023

08:00 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Unaudited NAV for November 2023

8 Dezember 2023

08:00 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Portfolio Company Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass Trial

13 November 2023

17:00 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Correction: Portfolio Company Aura Biosciences Announces Closing of $99 million Public Offering of Common Stock

10 November 2023

09:00 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Portfolio Company Aura Biosciences Announces Closing of $99 million Public Offering of Common Stock

08:00 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

PDMR Notification & Director Shareholding

8 November 2023

08:00 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Unaudited NAV for October 2023

3 November 2023

17:30 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

PDMR Notification & Director Shareholding

2 November 2023

19:20 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

PDMR Notification & Director Shareholding

1 November 2023

17:30 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102

24 Oktober 2023

08:00 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Portfolio company Harpoon Therapeutics announces up to $150 million private placement

6 Oktober 2023

08:00 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Unaudited NAV for September 2023

27 September 2023

08:01 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Interim Results for the Six Months Ended 30 June 2023

08:00 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Board Change

14 September 2023

08:01 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Notice of Results and Investor Presentation

08:00 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Unaudited NAV for August 2023

7 August 2023

08:00 UK Regulatory EN

Arix Bioscience PLC

UK Regulatory
EN

Unaudited NAV for July 2023

Anstehende Events

Keine Events gefunden